OVERVIEW
Meril develops innovative TAVR and TEER transcatheter solutions for aortic and mitral valve diseases, combining device innovation with procedural needs to support physicians in advancing minimally invasive therapies.
Untreated eligible patients.
Global RHD population
2-year mortality, severe AS
Severe AS in adults 75+
Replacement
TAVR
Repair
TEER
Restoring valve function with a less invasive approach for patients with severe aortic stenosis.
A minimally invasive option for mitral valve regurgitation, designed to reduce regurgitation and improve patient outcomes.
STRUCTURAL HEART ECOSYSTEM
Meril provides structural heart therapies, technologies, and procedural solutions to support physicians from planning through treatment and care.
FEATURED PRODUCTS
Heart valve designed for Transcatheter
Transcatheter heart valve designed for transcatheter aortic valve replacement (TAVR) procedures. Engineered for precise positioning and deployment across a range of patient anatomies.
Know MoreGlobal Presence
Stay updated on medical innovations, patient awareness initiatives, and insights shaping the future of global healthcare.
WLorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. laboris nisi ut aliquip ex ea commodo consequat.
Know MoreWLorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. laboris nisi ut aliquip ex ea commodo consequat.
Know MoreF A Q
Find quick answers on Meril's heart valves, therapies, and clinical data
